VHIR Annual Report 201

Vall d'Hebron. Institut de Recerca

CIBBIM – Nanomedicine

publications: 11

impact factor: 43.031

average impact factor: 3.912

Nanomedicine can be defined as the use of nanotechnology in biomedical applications mainly with two purposes: first, to improve therapeutic strategies and second, to improve the diagnostics.
We work in three different areas: the first one aims to obtain new biomarkers and therapeutic targets, the second one to obtain and generate new diagnosis systems, most of the based on the same biomarkers or targeting systems obtained in the first area. The third area is the one devoted to the validation of those systems in preclinical models, meaning either in vitro or in vivo models.